Download | < Back |
16 May 2015 | |
Aurobindo Pharma Ltd has submitted to BSE the Code of Practices and Procedures for Fair Disclosure of Un-Published Price Sensitive Information formulated pursuant to the provisions of Regulation 8 of SEBI (Prohibition of Insider Trading) Regulations, 2015 which has been approved by the Board of Directors of the Company. | |
View all announcements for AUROBINDO PHARMA LTD. | Source: BSE India |